Another chapter in the pemetrexed saga: Barcelona Commercial Court No. 4 has ruled on infringement in the very first case worldwide concerning pemetrexed diarginine, a salt form of pemetrexed chosen by Sandoz in the wake of the outcome of the landmark Actavis case of the Supreme Court of the United Kingdom (Judgment dated 12 July 2017). In preliminary injunction proceedings, the Spanish Court held that pemetrexed diarginine was also an infringing equivalent to pemetrexed disodium and, in doing so, makes some interesting findings.
Case date: 04 June 2020
Case number: Ruling No. 76/2020
Court: Commercial Court of Barcelona
A full summary of this case has been published on Kluwer IP Law.